FROM
Name*
Number*
Products*
- Case 1
- Case 2
- Case 3
- Case 4
Case 1
PRIMARY RAT NEURON CELLS
SOLATION CULTURE
Case 2
CELL BIOLOGICAL FUNCTIONS
AND MECHANISMS STUDY
Case 3
MCAO MODEL IN VIVO EXPERIMENT PHASE
GUAN STUDY
Case 4
BREEDING IDENTIFICATION OF
GENE KNOCKOUT MICE
- TECHNICAL TEAM
- COOPERATION PLATFORM
- EXPERIMENTAL EQUIPMENT
- STANDARDIZED TEST SITE
- PERFECT RESEARCH PLATFORM
PROFESSIONAL TECHNICAL TEAM
A COMPANY ATTACHES GREAT IMPORTANCE TO INNOVATION, PAY ATTENTION TO INDUSTRY-UNIVERSITY-RESEARCH COOPERATION, PAY ATTENTION TO THE INTRODUCTION OF HIGH-END SCIENTIFIC RESEARCH TALENTS; THE COMPANY HAS AN EXPERT ADVISORY TEAM OF 7 THOUSAND EXPERTS, 2 YANGTZE RIVER SCHOLARS, 2 OVERSEAS ACADEMICIANS; AT THE SAME TIME, IT ALSO HAS A TEAM OF 320 OVERSEAS SCIENTIFIC RESEARCH CONSULTANTS; THERE ARE MORE THAN 100 FIXED R&D PERSONNELS.
COOPERATION PLATFORM
CERTAIN BIOLOGY HAS ESTABLISHED CLOSE INDUSTRY-UNIVERSITY-RESEARCH COOPERATIVE RELATIONS WITH AUSTRALIA UNIVERSITY, NEW SOUTH WALES UNIVERSITY, GREE UNIVERSITY, SHANGHAI INSTITUTE, SHANGHAI FU UNIVERSITY, BEIJING INSTITUTE, PEKING UNIVERSITY, ARMY UNIVERSITY, CHONGQING UNIVERSITY COLLEGE, WEST UNIVERSITY, CHONGQING UNIVERSITY.
ADVANCED EXPERIMENTAL EQUIPMENT
WITH FIXED R&D ASSETS OF MORE THAN 60 MILLION YUAN, THE COMPANY HAS SEVEN BASIC BIOMEDICAL PLATFORMS AND FOUR INNOVATIVE R&D CENTERS, AND ITS MOLECULAR DIAGNOSTIC CENTER HAS MATURE MOLECULAR DIAGNOSTIC R&D EQUIPMENT AND INFRASTRUCTURE. THE R&D CENTER SITE IS MORE THAN 2,000 SQUARE METERS, AND IT HAS AN SPF ANIMAL CENTER THAT CAN PURIFY 10,000 CELLS AND FEED 9,000 EXPERIMENTAL ANIMALS AT THE SAME TIME.
STANDARDIZED TEST SITE
CERTAIN BIOLOGICAL IS HIGH-TECH ENTERPRISES, SCIENCE AND TECHNOLOGY ENTERPRISES, NEW RESEARCH AND DEVELOPMENT INSTITUTIONS, SPECIALIZED SPECIAL NEW ENTERPRISES, CERTAIN CITY AND CERTAIN DISTRICT BIOLOGICAL MEDICINE AND HEALTH ASSOCIATION VICE PRESIDENT UNIT, HEAVY A CERTAIN CITY PHARMACEUTICAL INDUSTRY ASSOCIATION VICE PRESIDENT UNIT.
PERFECT RESEARCH PLATFORM
CELL BIOLOGY RESEARCH PLATFORM, MOLECULAR BIOLOGY RESEARCH PLATFORM, PATHOLOGY RESEARCH PLATFORM, IMMUNOLOGY RESEARCH PLATFORM, TRANSGENIC AND MODEL ANIMAL RESEARCH PLATFORM, PROTEIN AND MULTIPLE RESEARCH PLATFORM; CRISPR/CAS9 TARGETED GENE MODIFICATION DRUG DEVELOPMENT PLATFORM, NANO TARGETED DRUG DELIVERY INNOVATION PLATFORM, HIGH THROUGHPUT/HIGH CONTENT SCREENING PLATFORM, MOLECULAR EPIGENETICS RESEARCH PLATFORM.